| Q34024535 | A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma |
| Q37118191 | Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions |
| Q26864261 | Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis |
| Q45739008 | Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients--experience from an Australian hepatobiliary unit |
| Q57812099 | Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis |
| Q34580778 | Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients |
| Q47158857 | Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection |
| Q50053599 | Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: A randomized controlled trial. |
| Q53112010 | Computer-Assisted Hepatocellular Carcinoma Ablation Planning Based on 3-D Ultrasound Imaging. |
| Q42648934 | Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria |
| Q37821277 | Current status of radiofrequency ablation of hepatocellular carcinoma |
| Q38257936 | Current treatment for small (< 5 cm) hepatocellular carcinoma: evolving roles for ablation and resection |
| Q28391394 | Dickkopfs and Wnt/β-catenin signalling in liver cancer |
| Q35180185 | Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies |
| Q85562799 | Endoscopic versus open radiofrequency ablation for treatment of small hepatocellular carcinoma |
| Q27002551 | Evolving ablative therapies for hepatic malignancy |
| Q91998267 | Immunomodulatory Changes Following Isolated RF Ablation in Colorectal Liver Metastases: A Case Report |
| Q36637249 | Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's view |
| Q37795703 | Is it time to reconsider the BCLC/AASLD therapeutic flow‐chart? |
| Q89747123 | MELD score and AST-to-platelet ratio index (APRI) predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study |
| Q38827648 | Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2. |
| Q33629394 | Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma |
| Q36376904 | Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma |
| Q30468280 | Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? |
| Q88598857 | Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade |
| Q24201669 | Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma |
| Q30473747 | Radiofrequency ablation of hepatocellular carcinoma: a literature review |
| Q41683441 | Radiofrequency ablation of hepatocellular carcinoma: pros and cons |
| Q41849760 | Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials |
| Q34939487 | Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis. |
| Q37808143 | Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies |
| Q34547772 | Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysis |
| Q30460837 | Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma |
| Q51508291 | Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience. |
| Q36561656 | Role of surgical resection for multiple hepatocellular carcinomas |
| Q36570322 | Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors |
| Q87279251 | Surgical resection versus open-approach radiofrequency ablation for small hepatocellular carcinomas within Milan criteria after successful transcatheter arterial chemoembolization |
| Q38122362 | Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma |
| Q39184664 | The clinical utility of RFA in esophageal and cardia cancer patients with severe malignant obstruction |
| Q38055031 | The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma--indication, technique and results. |
| Q41194963 | The role of liver transplantation or resection for patients with early hepatocellular carcinoma |
| Q35037545 | Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review |
| Q39341768 | Update on the Mechanisms of Liver Regeneration |